FERRAIOLI, MARIO
FERRAIOLI, MARIO
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study
2024-01-01 Conigliaro, P; D’Antonio, A; Wlderk, A; Sabuzi, F; Ferraioli, M; Sichi, L; Da Ros, V; Biancone, L; Bergamini, A; Chimenti, Ms
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
2022-01-01 Ramonda, R; Lorenzin, M; Chimenti, Ms; D’Angelo, S; Marchesoni, A; Salvarani, C; Lubrano, E; Costa, L; Dal Bosco, Y; Fracassi, E; Ortolan, A; Ferraioli, M; Carriero, A; Visalli, E; Bixio, R; Desiati, F; Bergamini, A; Pedrollo, E; Doria, A; Foti, R; Carletto, A
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
2024-07-15 Ramonda, R; Lorenzin, M; Chimenti, Ms; D'Angelo, S; Marchesoni, A; Selmi, C; Lubrano, E; Santo, L; Luchetti Gentiloni, Mm; Atzeni, F; Cauli, A; Manara, M; Rossini, M; Foti, R; Cozzi, G; Scagnellato, L; Ferraioli, M; Carriero, A; Luciano, N; Ruzzon, F; Fatica, M; Fracassi, E; Doria, A; Foti, R; Carletto, A
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
2023-09-16 Scriffignano, S; Perrotta, Fm; Conigliaro, P; Ferraioli, M; Triggianese, P; Chimenti, Ms; Lubrano, E
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
2023-11-02 Picchianti-Diamanti, A; Navarra, A; Aiello, A; Laganà, B; Cuzzi, G; Salmi, A; Vanini, V; Maggi, F; Meschi, S; Matusali, G; Notari, S; Agrati, C; Salemi, S; Di Rosa, R; Passarini, D; Di Gioia, V; Sesti, G; Conti, F; Spinelli, Fr; Corpolongo, A; Chimenti, Ms; Ferraioli, M; Sebastiani, Gd; Benucci, M; Li Gobbi, F; Santoro, Ap; Capri, A; Puro, V; Nicastri, E; Goletti, D
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review
2024-01-01 Ferraioli, M; Fiannacca, L; Greco, E; Cela, E; Fatica, M; Bergamini, A; Chimenti, Ms
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts
2023-01-01 Massimo Perrotta, F; Scriffignano, S; Triggianese, P; Ferraioli, M; Chimenti, Ms; Lubrano, E
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis
2024-07-26 Caso, F; Fatica, M; Ferraioli, M; Megna, M; Potestio, L; Ruggiero, A; Tommasino, N; Maione, F; Scarpa, R; Chimenti, Ms; Costa, L
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study | Conigliaro, P; D’Antonio, A; Wlderk, A; Sabuzi, F; Ferraioli, M; Sichi, L; Da Ros, V; Biancone, L; Bergamini, A; Chimenti, Ms | Articolo su rivista | |
| 1-gen-2022 | Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study | Ramonda, R; Lorenzin, M; Chimenti, Ms; D’Angelo, S; Marchesoni, A; Salvarani, C; Lubrano, E; Costa, L; Dal Bosco, Y; Fracassi, E; Ortolan, A; Ferraioli, M; Carriero, A; Visalli, E; Bixio, R; Desiati, F; Bergamini, A; Pedrollo, E; Doria, A; Foti, R; Carletto, A | Articolo su rivista | |
| 15-lug-2024 | Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis | Ramonda, R; Lorenzin, M; Chimenti, Ms; D'Angelo, S; Marchesoni, A; Selmi, C; Lubrano, E; Santo, L; Luchetti Gentiloni, Mm; Atzeni, F; Cauli, A; Manara, M; Rossini, M; Foti, R; Cozzi, G; Scagnellato, L; Ferraioli, M; Carriero, A; Luciano, N; Ruzzon, F; Fatica, M; Fracassi, E; Doria, A; Foti, R; Carletto, A | Articolo su rivista | |
| 16-set-2023 | Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis | Scriffignano, S; Perrotta, Fm; Conigliaro, P; Ferraioli, M; Triggianese, P; Chimenti, Ms; Lubrano, E | Articolo su rivista | |
| 2-nov-2023 | Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine | Picchianti-Diamanti, A; Navarra, A; Aiello, A; Laganà, B; Cuzzi, G; Salmi, A; Vanini, V; Maggi, F; Meschi, S; Matusali, G; Notari, S; Agrati, C; Salemi, S; Di Rosa, R; Passarini, D; Di Gioia, V; Sesti, G; Conti, F; Spinelli, Fr; Corpolongo, A; Chimenti, Ms; Ferraioli, M; Sebastiani, Gd; Benucci, M; Li Gobbi, F; Santoro, Ap; Capri, A; Puro, V; Nicastri, E; Goletti, D | Articolo su rivista | |
| 1-gen-2024 | Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review | Ferraioli, M; Fiannacca, L; Greco, E; Cela, E; Fatica, M; Bergamini, A; Chimenti, Ms | Articolo su rivista | |
| 1-gen-2023 | Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts | Massimo Perrotta, F; Scriffignano, S; Triggianese, P; Ferraioli, M; Chimenti, Ms; Lubrano, E | Articolo su rivista | |
| 26-lug-2024 | The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis | Caso, F; Fatica, M; Ferraioli, M; Megna, M; Potestio, L; Ruggiero, A; Tommasino, N; Maione, F; Scarpa, R; Chimenti, Ms; Costa, L | Articolo su rivista |